Results 31 to 40 of about 14,831 (169)

Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations

Precision Medical Sciences, EarlyView.
Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik, Arif Malik, Shahzad Ahmad, Hassan Mohsin, Shazia Iqbal   +4 more
wiley   +1 more source

Small‐Scale Magnetic Soft Robots for Medical Applications: From Laboratory to Clinical Use

SmartBot, EarlyView.
Small‐scale magnetic soft robots are emerging as promising platforms for minimally invasive diagnosis and therapy in complex in vivo environments. This review compares untethered and tethered medical magnetic robots in parallel across five translational stages, from basic performance testing to clinical evaluation.
Xingxing Ke, Shizhi Li, Tianrui Zhang, Yue Zhong, Songyang Li, Shuo Zhang, Zhiping Chai, Menghao Pu, Zisheng Zong, Haochen Yong, Xingxing Dong, Lanting Huang, Zhen Deng, Shuaizheng Yan, Yue Zhang, Zhaoju Zhu, Mingzhu Zhu, Linze Li, Ruiquan Chen, Shu Zhang, Chong Wu, Di Wu, Lei Yang, Rui Chen, Tongzhi Niu, Hongling Qin, Han Ding, Bingwei He, Siqi Wu, Zhigang Wu   +29 more
wiley   +1 more source

A Droplet‐Microarray Platform for Multiplex Profiling of Breast Cancer Exosome Subtypes in Patients’ Blood Plasma Samples

Small, EarlyView.
This study presents a droplet‐microarray platform integrated with a DNase I‐assisted MoS2 FRET aptasensor for multiplexed profiling of breast cancer subtypes’ exosomes from patients’ plasma. By targeting HER2, MUC1, and CD44, the system enables sensitive detection and accurate discrimination of luminal A, HER2‐positive, and triple‐negative subtypes ...
Yi Liu, Ruolin Zhang, Jialei Song, Meng Xiao, Yue Meng, Zhiyang Li, Jingyu Shi, Yunyan Tai, Bing Gu, Mo Yang   +9 more
wiley   +1 more source

Categorized contrast enhanced mammography dataset for diagnostic and artificial intelligence research

Scientific Data, 2022
Measurement(s) Dual-Energy Contrast-Enhanced Digital Spectral Mammography Technology Type(s) digital curation Sample Characteristic - Organism Homo sapiens • Breast Sample Characteristic - Location ...
Rana Khaled, Maha Helal, Omar Alfarghaly, Omnia Mokhtar, Abeer Elkorany, Hebatalla El Kassas, Aly Fahmy   +6 more
doaj   +1 more source

Combined Contrast Enhanced Mammography and Digital Breast Tomosynthesis in Patients Suspected of Having Breast Cancer: A Prospective Comparison With Digital Mammography and Breast MRI—Findings of the CONTEST Study

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction We aimed to assess diagnostic performance and accuracy for local staging of CEM combined with DBT (CE + DBT) compared to digital mammography (DM) and MRI. Methods Female patients aged 18–70 years with clinical or sonographic suspicion of breast cancer had CE + DBT and breast MRI prior to treatment.
Sarah L. Savaridas, Kulsam Ali, Sarah Vinnicombe, Petra Rauchhaus, Andrew J. Evans, Nisha Sharma, Sally Bolt, Patsy Whelehan   +7 more
wiley   +1 more source

Contrast enhanced digital mammography: Is it useful in detecting lesions in edematous breast?

The Egyptian Journal of Radiology and Nuclear Medicine, 2015
Introduction: Breast edema can be caused by a variety of pathologic processes of benign or malignant diseases. Contrast enhanced digital mammogram (CEDM) has been shown to improve the probability of malignancy detection when compared with the ...
Noha Abd ElShafy ElSaid, Samah Farouk, Ola Magdy Mohamed Shetat, Nagat Mansour Khalifa, Omnia Mokhtar Nada   +4 more
doaj   +1 more source

The added advantage of automated breast ultrasound to mammographically detected different breast lesions in patients with dense breasts

The Egyptian Journal of Radiology and Nuclear Medicine, 2020
Background Breast cancer is the most commonly diagnosed malignancy in women worldwide. Women with dense breast tend to have 15–25% lifetime risk of breast cancer due to decrease of mammographic sensitivity.
Engy A. Ali, Alaa M. Ahmed, Noha A. Elsaid   +2 more
doaj   +1 more source

Diagnostic value of contrast-enhanced mammography in the characterization of breast asymmetry

The Egyptian Journal of Radiology and Nuclear Medicine, 2022
Background Breast asymmetry is a prevalent mammographic finding described in BI-RADS atlas as asymmetry, focal asymmetry, global asymmetry, and developing asymmetry. Mammography has a limited role in discrimination between benign and malignant asymmetry,
Bassant Mahmoud Dawoud, Abdelmonem Nooman Darweesh, Mohamed Mohamed Hefeda, Rasha Mohamed Kamal, Rasha Lotfy Younis   +4 more
doaj   +1 more source

S1 guideline sweat gland carcinoma

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The current classification of sweat gland carcinomas is based on histomorphological characteristics and distinguishes between more than 20 entities. Most patients are older, but some subtypes also affect middle‐aged and younger patients. The majority of tumors arise de novo. Sweat gland carcinomas have nonspecific clinical features.
Mirjana Ziemer, Michael Erdmann, Abbas Agaimy, Jürgen C. Becker, Almut Böer‐Auer, Doris Helbig, Cornelia Erfurt‐Berge, Alexander Frisman, Conrad Hempel, Ulrike Leiter, Friedegund Meier, Thomas Mentzel, Lara Racz, Silke Redler, Stefan Schliep, Clemens Seidel, Alpaslan Tasdogan, Jochen Utikal, Carsten Weishaupt, Selma Ugurel   +19 more
wiley   +1 more source

THE DETECTION AND BIOPSY OF BREAST DISEASES: ROLE OF IMAGING

Journal of the Dow University of Health Sciences, 2007
Advances in the imaging o f breast have paralleled the increased detection o f carcinoma breast. Although mammography remains the gold standard with a phenomenal backup by ultrasound; the natural architectural variations along with the discom fort o f
saba sohail
doaj   +2 more sources